1,4-Butanediol

1,4-Butanediol

SCHEMBL575604

CCS(=O)(=O)O.CCS(=O)(=O)O.OCCCCO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

FGFR1FGFR2FGFR3FGFR4FLT1FLT4KDRPDGFRAPDGFRB

The experimentally established mechanism targets of 1,4-Butanediol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 3/20 0.47
ALDH1A1 P00352 3/20 0.47
TSHR P16473 2/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
KDM4E B2RXH2 1/20 0.39
CYP4F2 P78329 2/20 0.37
CYP4A11 Q02928 2/20 0.37
GPR84 Q9NQS5 1/20 0.35
APP P05067 1/20 0.35
FFAR1 O14842 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
CA2 P00918 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
TP53 P04637 1/20 0.32
PTGS1 P23219 1/20 0.32
PDE4A P27815 1/20 0.32
SLC6A6 P31641 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,3-Propanediol SCHEMBL575455 0.93 ALDH1A1 (0.44) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
1,4-Butanediol SCHEMBL2167602 0.89 SMN1; SMN2 (0.41) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
1,4-Butanediol SCHEMBL2168624 0.89 SMN1; SMN2 (0.41) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
Tridecan-1-Ol SCHEMBL28721719 0.87 LMNA (0.65) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
Ethylene Glycol SCHEMBL28390899 0.86 TSHR (0.39) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
Ethylene Glycol SCHEMBL29024223 0.86 TSHR (0.39) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
1,4-Butanediol SCHEMBL575703 0.83 SMN1; SMN2 (0.48) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
SCHEMBL11145288 0.83 APP (0.52) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
1,4-Butanediol SCHEMBL20236034 0.83 SMN1; SMN2 (0.48) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
1,4-Butanediol SCHEMBL15301979 0.83 SMN1; SMN2 (0.44) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240297344-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-05 US disclosed
US-11616253-B2 Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2023-03-28 US disclosed
US-20220278370-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2022-09-01 US disclosed
US-11367899-B2 Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2022-06-21 US disclosed
US-11114693-B2 Electrolytic solution for nonaqueous electrolytic solution secondary batteries and nonaqueous electrolytic solution secondary battery CENTRAL GLASS COMPANY, LTD. (JP) 2021-09-07 US disclosed
EP-3333962-B1 ELECTROLYTIC SOLUTION FOR NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERIES AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY CENTRAL GLASS CO LTD (JP) 2020-10-07 EP disclosed
US-20200212485-A1 Non-Aqueous Electrolyte Solution and Non-Aqueous Electrolyte Battery in Which Same Is Used CENTRAL GLASS COMPANY, LIMITED (JP) 2020-07-02 US disclosed
US-10468720-B2 Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2019-11-05 US disclosed
US-20190288338-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2019-09-19 US disclosed
EP-2144321-B1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEM CORP (JP) 2019-01-23 EP disclosed
EP-2360771-A1 Nonaqueous electrolytic solutions and nonaqueous-electrolyte batteries Mitsubishi Chemical Corporation (JP) 2011-08-24 EP disclosed
US-20100255384-A1 Nonaqueous electrolyte secondary battery PANASONIC ENERGY CO., LTD (JP) 2010-10-07 US disclosed
US-7767343-B2 Nonaqueous electrolyte secondary battery using lithium cobalt oxide as a positive active material and a nonaqueous electrolyte containing a sulfonyl-containing compound UBE INDUSTRIES LTD. (JP) 2010-08-03 US disclosed
US-20100119956-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2010-05-13 US disclosed
EP-2144321-A1 NONAQUEOUS ELECTROLYTE FOR RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE Mitsubishi Chemical Corporation (JP) 2010-01-13 EP disclosed
US-20090253045-A1 NONAQUEOUS ELECTROLYTIC SOLUTIONS AND NONAQUEOUS-ELECTROLYTE BATTERIES MITSUBISHI CHEMICAL CORPORATION (JP) 2009-10-08 US disclosed
EP-2031689-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY Mitsubishi Chemical Corporation (JP) 2009-03-04 EP disclosed
EP-1739783-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Ube Industries, Ltd. (JP) 2007-01-03 EP disclosed
US-20060166096-A1 Nonaqueous electrolyte secondary battery PANASONIC ENERGY CO., LTD (JP) 2006-07-27 US disclosed
US-6436582-B1 A NON-AQUEOUS SOLVENT AND (II) AN ELECTROLYTE SALT DISSOLVED THEREIN AND (III) A DISULFONATE ESTER DERIVATIVE UBE INDUSTRIES, LTD. (JP) 2002-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11114693-B2 Electrolytic solution for nonaqueous electrolytic solution secondary batteries and nonaqueous electrolytic solution secondary battery ESPL1, TST, PEF1 SMN1; SMN2 869/4885LMNA 2885/4885ALDH1A1 1379/4885
US-20200212485-A1 Non-Aqueous Electrolyte Solution and Non-Aqueous Electrolyte Battery in Which Same Is Used SLC9A1, TST, CA1 SMN1; SMN2 735/4885LMNA 3281/4885ALDH1A1 891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.